Stay updated on Dapirolizumab Pegol Safety in Lupus Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.

Latest updates to the Dapirolizumab Pegol Safety in Lupus Clinical Trial page
- Check5 days agoChange DetectedA new version of the lupus clinical trial record was submitted on October 14, 2026, and posted October 15, with updates to study status and contacts/locations.SummaryDifference0.2%

- Check12 days agoChange DetectedThe site footer revision label updated from v3.7.0 to v3.7.1, while the clinical study record history remained unchanged.SummaryDifference0.0%

- Check19 days agoChange DetectedA new study-record version dated 2026-10-02 was added, documenting updates to the study status and contacts/locations. The history also reflects a date change around the prior version.SummaryDifference0.2%

- Check33 days agoChange DetectedDifference0.2%

- Check47 days agoChange DetectedA new history entry appears on 2026-09-04 introducing Contacts/Locations and Study Status sections to the record history. An entry from 2026-08-21 was removed.SummaryDifference0.2%

- Check54 days agoChange DetectedRevision in the footer changed from v3.6.5 to v3.6.6. This reflects a new system release of the ClinicalTrials.gov interface.SummaryDifference0.0%

Stay in the know with updates to Dapirolizumab Pegol Safety in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.